Ovarian Cancer

Almost a third of women with low-grade serous ovarian cancer saw their tumours shrink or stop growing when taking a combination of avutometinib and defactinib.

Two women from Guernsey are calling for urgent investments in cancer research after discovering they share the same faulty gene that increases their risk.

Emma Cox's mum Rose died in December last year. The 64-year-old had ovarian cancer - a disease which is not picked up through routine screening.